NASDAQ:FENC

Fennec Pharmaceuticals Stock Insider Trading

etoro logo Buy FENC
*Your capital is at risk
$9.14
-0.84 (-8.42%)
At Close: Jun 03, 2026

Fennec Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -80.27. In total, the insiders bought 1.25M and sold 1.49M FENC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-80.27
Buy 1.25M shares
Sell 1.49M shares
79% Buy Activity
Weak Negative Correlation
Buy Signal Low Confidence
Mar 31, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -80.27.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (79% buys).

Historical Insider Trades

Date Type Person Role Amount
Jun 01, 2026
Sell
Common shares
S-Sale
Raykov Rosty
Director
Director 9 747
Value: $93.8K
Jun 01, 2026
Buy
Common shares
M-Exempt
Raykov Rosty
Director
Director 15 597
Value: $38.2K
Jun 01, 2026
Buy
Stock Options
M-Exempt
Raykov Rosty
Director
Director 15 597
Value: $38.2K
May 31, 2026
Buy
Common shares
A-Award
Raykov Rosty
Director
Director 2 778
Value: $25.4K
May 31, 2026
Buy
Common Shares
A-Award
Hackman Jeffrey S.
Chief Executive Officer
CEO / President 1 159
Value: $10.6K
May 31, 2026
Buy
Common Shares
A-Award
Sayad Pierre Sargis
Chief Medical Officer
Officer 168
Value: $2K
May 31, 2026
Buy
Common shares
A-Award
Cioffi Christiana Marie
Chief Strategy Officer
Officer 156
Value: $1K
May 31, 2026
Buy
Common Shares
A-Award
Evans Terry L
Chief Commercial Officer
Officer 168
Value: $2K
May 31, 2026
Buy
Common shares
A-Award
Andrade Robert
Chief Financial Officer
C-Suite Officer 1 703
Value: $15.6K
May 11, 2026
Sell
Common Shares
S-Sale
Rallis Chris A
Director
Director 8 346
Value: $58.8K
May 11, 2026
Buy
Stock Option
M-Exempt
Rallis Chris A
Director
Director 14 344
Value: $35.0K
May 11, 2026
Buy
Common Shares
M-Exempt
Rallis Chris A
Director
Director 14 344
Value: $35.0K
May 01, 2026
Sell
Common shares
S-Sale
Raykov Rosty
Director
Director 10 781
Value: $69.8K
May 01, 2026
Buy
Stock Options
M-Exempt
Raykov Rosty
Director
Director 15 598
Value: $38.2K
May 01, 2026
Buy
Common shares
M-Exempt
Raykov Rosty
Director
Director 15 598
Value: $38.2K
Apr 30, 2026
Buy
Common Shares
M-Exempt
Sayad Pierre Sargis
Chief Medical Officer
Officer 168
Value: $1K
Apr 30, 2026
Buy
Common shares
M-Exempt
Cioffi Christiana Marie
Chief Strategy Officer
Officer 155
Value: $1K
Apr 30, 2026
Buy
Common shares
M-Exempt
Raykov Rosty
Director
Director 2 778
Value: $18.0K
Apr 30, 2026
Buy
Common Shares
M-Exempt
Evans Terry L
Chief Commercial Officer
Officer 168
Value: $1K
Apr 30, 2026
Buy
Common Shares
M-Exempt
Hackman Jeffrey S.
Chief Executive Officer
CEO / President 1 159
Value: $8K
Apr 30, 2026
Buy
Common shares
M-Exempt
Andrade Robert
Chief Financial Officer
C-Suite Officer 1 703
Value: $11.1K
Apr 01, 2026
Buy
Common shares
M-Exempt
Raykov Rosty
Director
Director 15 598
Value: $38.2K
Apr 01, 2026
Buy
Stock Options
M-Exempt
Raykov Rosty
Director
Director 15 598
Value: $38.2K
Apr 01, 2026
Sell
Common shares
S-Sale
Raykov Rosty
Director
Director 10 946
Value: $69.1K
Mar 31, 2026
Buy
Common Shares
M-Exempt
Evans Terry L
Chief Commercial Officer
Officer 18 456
Value: $113.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT FENNEC PHARMACEUTICALS, INC
Fennec Pharmaceuticals
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is ba...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE